window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

drug discovery

  • Biotech & Pharma Business

    PhoreMost brings in biotech major players with $30B+ in deal history

    Company says appointments of Barbara Duncan and Stephen Dilly will [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    BioAscent taps new VP of Alliance Management to drive global growth

    BioAscent has appointed seasoned drug discovery executive Dr James Hitchin [...]

    May 5, 2026
  • Advanced Therapies

    Cellevate, Fraunhofer IBMT, and OLS secure Eurostar grant to advance large-scale iPSC production

    Cellevate AB, Fraunhofer IBMT, and Omni Life Science (OLS) have [...]

    May 5, 2026
  • Biotech & Pharma Business

    CN Bio and Pharmaron partner to expand organ-on-a-chip adoption and innovation

    May 5, 2026
  • Biotech & Pharma Business

    Immunai and Parker Institute partner on landmark single-cell cancer dataset

    May 5, 2026
Previous56

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Inaqovi combination wins EU approval for AML treatment
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Grifols doses first patient in Phase 3 alpha-1 therapy trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Genoskin expands US production of primary human mast cells
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top